← Russell 3000 cross-section

CORZ Core Scientific, Inc./tx

Trailing twelve months to 2026-06-30 · as filed 2026-07-28, not restated
Financials

Scale

Market cap
$5.8bn
Revenue TTM
$440m
Net income TTM
$-1.4bn
Free cash flow
$-958m
Composite score
Sector rank
#985

Valuation

P / E
EV / EBITDA
EV / sales
18.9
FCF yield
-16.50%
Earnings yield vs 10-yr
-29.46pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-325.9%
EBITDA margin
-114.2%
ROE
59.3%
ROIC
-519.5%
Revenue growth
26.4%

Insider activity, last 90 days

Net open-market
$-2.83m
Buyers
2
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The fair value of electrical equipment held for sale was determined using a market approach based on observed sales prices for comparable equipment. Notes to Unaudited Condensed Consolidated Financial Statements The following table presents revenue and gross profit by reportable segment for the periods indicated (dollars in thousands): (1) Other segment items consist primarily of software and IT costs, travel, professional and contract services, and telecommunications costs. Core Scientific, Inc. …Core Scientific, Inc./tx, 10-Q, period ended 2026-06-30, filed 2026-07-28

Read the full passage →